Search all trials

Find therapies in clinical trials near you – page 11

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Diabetic neuropathy

Not recruiting

Investigational

Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Cannabis Sativa Flower

Contact Research Centre

Acute myeloid leukaemia+10

Not recruiting

InvestigationalNo placebo

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Registered drug

Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Chronic myeloid leukaemia (in remission)

Not recruiting

Registered drugNo placebo

Study on Stopping Nilotinib, Imatinib, and Dasatinib in Patients with Chronic Myeloid Leukemia in Deep Remission

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Dasatinib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin

Contact Research Centre

Major depression

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Aticaprant

Contact Research Centre

Chronic lymphocytic leukaemia refractory

Not recruiting

Registered drugNo placebo

Study Comparing Acalabrutinib to Standard Treatments for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Major depression+1

Not recruiting

Investigational

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Investigational

Czechia

Participants:18–64 years
Substances:Aticaprant

Contact Research Centre

Find therapies in clinical trials near you – page 11

187 trials match your criteria

Chronic lymphocytic leukaemia

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Diabetic neuropathy

Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

Acute myeloid leukaemia+10

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

Chronic spontaneous urticaria

Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

Plasma cell myeloma

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Plasma cell myeloma

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Chronic myeloid leukaemia (in remission)

Study on Stopping Nilotinib, Imatinib, and Dasatinib in Patients with Chronic Myeloid Leukemia in Deep Remission

Plasma cell myeloma

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Plasma cell myeloma refractory

Study of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy

Major depression

Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

Chronic lymphocytic leukaemia refractory

Study Comparing Acalabrutinib to Standard Treatments for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Major depression+1

Study on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.